Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

Similar articles for PubMed (Select 24028720)

1.

[Clinical features of adult patients with Eisenmenger syndrome associated with different types of congenital heart disease].

Chen G, He JG, Liu ZH, Gu Q, Ni XH, Zhao ZH, Xiong CM.

Zhonghua Yi Xue Za Zhi. 2013 May 28;93(20):1546-9. Chinese.

PMID:
24028720
2.

[Screening study of pulmonary arterial hypertension in patients with congenital heart diseases].

Sun YJ, Pang KJ, Zeng WJ, Wang H, He JG.

Zhonghua Yi Xue Za Zhi. 2012 Apr 24;92(16):1091-4. Chinese.

PMID:
22781765
3.
4.

Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.

D'Alto M, Romeo E, Argiento P, Sarubbi B, Santoro G, Grimaldi N, Correra A, Scognamiglio G, Russo MG, Calabrò R.

Int J Cardiol. 2012 Mar 22;155(3):378-82. doi: 10.1016/j.ijcard.2010.10.051. Epub 2010 Nov 16.

PMID:
21081251
5.

Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).

Barst RJ, Ivy DD, Foreman AJ, McGoon MD, Rosenzweig EB.

Am J Cardiol. 2014 Jan 1;113(1):147-55. doi: 10.1016/j.amjcard.2013.09.032. Epub 2013 Oct 4.

PMID:
24176071
6.

Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.

Hopkins WE, Ochoa LL, Richardson GW, Trulock EP.

J Heart Lung Transplant. 1996 Jan;15(1 Pt 1):100-5.

PMID:
8820089
7.

Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study.

Garg N, Tripathy N, Sinha N.

Cardiol Young. 2011 Dec;21(6):631-8. doi: 10.1017/S1047951111000497. Epub 2011 Jun 8.

PMID:
21729508
8.

Long-term effect of bosentan therapy on cardiac function and symptomatic benefits in adult patients with Eisenmenger syndrome.

Kaya MG, Lam YY, Erer B, Ayhan S, Vatankulu MA, Nurkalem Z, Meric M, Eren M, Eryol NK.

J Card Fail. 2012 May;18(5):379-84. doi: 10.1016/j.cardfail.2012.02.004. Epub 2012 Mar 10.

PMID:
22555267
9.

The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.

Zeng WJ, Lu XL, Xiong CM, Shan GL, Liu ZH, Ni XH, Gu Q, Zhao ZH, Li JJ, He JG; Sildenafil Therapy on Pulmonary Arterial Hypertension Associated With Different Types of Congenital Heart Disease Study Group.

Clin Cardiol. 2011 Aug;34(8):513-8. doi: 10.1002/clc.20917. Epub 2011 Jun 15.

PMID:
21678455
10.

Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.

D'Alto M, Romeo E, Argiento P, Santoro G, Sarubbi B, Gaio G, Mélot C, Russo MG, Naeije R, Calabrò R.

Heart. 2010 Sep;96(18):1475-9. doi: 10.1136/hrt.2010.199661. Epub 2010 Jul 28.

PMID:
20668108
11.

[Multicenter study of disease attributes in adult patients with pulmonary hypertension].

Dong L, He JG, Liu ZH, Lu XL, Zeng WJ, Sun YJ, Ni XH, Gu Q, Zhao ZH, Cheng XS, Xiong CM.

Zhonghua Yi Xue Za Zhi. 2012 Apr 24;92(16):1087-90. Chinese.

PMID:
22781764
12.

[Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].

Kaemmerer H, Gorenflo M, Hoeper M, Huscher D, Ewert P, Pittrow D.

Dtsch Med Wochenschr. 2013 Jun;138(23):1247-52. doi: 10.1055/s-0033-1343189. Epub 2013 May 29. Review. German.

PMID:
23720182
13.

Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension.

Agapito AF, Sousa L, Oliveira JA, Feliciano J, Cacela D, Quininha J.

Rev Port Cardiol. 2005 Mar;24(3):421-31. English, Portuguese.

PMID:
15929625
14.

Eisenmenger syndrome due to a large ductus arteriosus.

Labombarda F, Kerros H, Grollier G.

Arch Cardiovasc Dis. 2010 Nov-Dec;103(11-12):623-5. doi: 10.1016/j.acvd.2010.02.004. No abstract available.

15.

[Immediately effects of inhaled aerosolised iloprost in adult patients with severe pulmonary hypertension secondary to congenital heart diseases].

Zhang CJ, Huang YG, Shen JJ, Huang T, Huang WH, Cui YL, Huang XS.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Jan;39(1):65-8. Chinese.

PMID:
21418801
16.

Noninvasive assessment of pulmonary artery flow and resistance by cardiac magnetic resonance in congenital heart diseases with unrestricted left-to-right shunt.

Bell A, Beerbaum P, Greil G, Hegde S, Toschke AM, Schaeffter T, Razavi R.

JACC Cardiovasc Imaging. 2009 Nov;2(11):1285-91. doi: 10.1016/j.jcmg.2009.07.009.

17.

A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.

Durongpisitkul K, Jakrapanichakul D, Sompradikul S.

J Med Assoc Thai. 2008 Feb;91(2):196-202.

PMID:
18389984
18.

Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.

Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M; Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators.

Circulation. 2006 Jul 4;114(1):48-54. Epub 2006 Jun 26.

19.

Efficacy and safety of bosentan in adults with simple and complex Eisenmenger's syndrome.

Williams R, Houser L, Miner P, Aboulhosn J.

Congenit Heart Dis. 2012 Jan-Feb;7(1):12-5. doi: 10.1111/j.1747-0803.2011.00606.x. Epub 2011 Dec 21.

PMID:
22188797
20.

Prognosis for patients with Eisenmenger syndrome of various aetiology.

Saha A, Balakrishnan KG, Jaiswal PK, Venkitachalam CG, Tharakan J, Titus T, Kutty R.

Int J Cardiol. 1994 Jul;45(3):199-207.

PMID:
7960265
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk